Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment

TerminatedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Hepatitis B

Interventions

DRUG

Tenofovir Disoproxil Fumarate

300mg, oral daily for two years

DRUG

Entecavir

0.5mg oral daily for two years.

Trial Locations (2)

New Discovery LLC, New York

Asian Pacific Liver Center at St. Vincent Medical Center, Los Angeles